Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Tonix Pharmaceuticals Holding (TNXP) Income from Continuing Operations (2023 - 2025)

Historic Income from Continuing Operations for Tonix Pharmaceuticals Holding (TNXP) over the last 3 years, with Q3 2025 value amounting to -$31.8 million.

  • Tonix Pharmaceuticals Holding's Income from Continuing Operations fell 10102.29% to -$31.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$97.7 million, marking a year-over-year increase of 3109.61%. This contributed to the annual value of -$136.7 million for FY2024, which is 3920.11% down from last year.
  • As of Q3 2025, Tonix Pharmaceuticals Holding's Income from Continuing Operations stood at -$31.8 million, which was down 10102.29% from -$27.4 million recorded in Q2 2025.
  • Over the past 5 years, Tonix Pharmaceuticals Holding's Income from Continuing Operations peaked at -$15.8 million during Q3 2024, and registered a low of -$77.3 million during Q2 2024.
  • Over the past 3 years, Tonix Pharmaceuticals Holding's median Income from Continuing Operations value was -$27.3 million (recorded in 2023), while the average stood at -$29.7 million.
  • Data for Tonix Pharmaceuticals Holding's Income from Continuing Operations shows a peak YoY increase of 6462.14% (in 2025) and a maximum YoY decrease of 10102.29% (in 2025) over the last 5 years.
  • Over the past 3 years, Tonix Pharmaceuticals Holding's Income from Continuing Operations (Quarter) stood at -$27.3 million in 2023, then grew by 17.72% to -$22.5 million in 2024, then crashed by 41.62% to -$31.8 million in 2025.
  • Its Income from Continuing Operations stands at -$31.8 million for Q3 2025, versus -$27.4 million for Q2 2025 and -$16.1 million for Q1 2025.